Literature DB >> 6300230

The activation of human monocytes by liposome-encapsulated muramyl dipeptide analogues.

G Lopez-Berestein, K Mehta, R Mehta, R L Juliano, E M Hersh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6300230

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  17 in total

1.  Effect of Nocardia rubra cell wall skeleton on augmentation of cytotoxicity function in human pleural macrophages.

Authors:  M Sakatani; T Ogura; T Masuno; S Kishimoto; Y Yamamura
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

Review 2.  Clinical Translation of Nanomedicine.

Authors:  Yuanzeng Min; Joseph M Caster; Michael J Eblan; Andrew Z Wang
Journal:  Chem Rev       Date:  2015-06-19       Impact factor: 60.622

3.  Effect of liposomal amphotericin B on murine macrophages and lymphocytes.

Authors:  R T Mehta; K Mehta; G Lopez-Berestein; R L Juliano
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

4.  Potentiation of direct antitumor cytotoxicity and production of tumor cytolytic factors in human blood monocytes by human recombinant interferon-gamma and muramyl dipeptide derivatives.

Authors:  S Sone; G Lopez-Berestein; I J Fidler
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

5.  Induction of tumouricidal leucocytes by the intranasal application of MTP-PE, a lipophilic muramyl peptide.

Authors:  A F Brownbill; D G Braun; P Dukor; G Schumann
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

6.  The systemic activation of macrophages by liposomes containing immunomodulators.

Authors:  R Nayar; I J Fidler
Journal:  Springer Semin Immunopathol       Date:  1985

7.  Effect of free or liposome-encapsulated muramyl dipeptide on uptake and intracellular survival of Listeria monocytogenes in mouse peritoneal macrophages in vitro.

Authors:  I A Bakker-Woudenberg; A F Lokerse; J C Vink-van den Berg; F H Roerdink
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-07       Impact factor: 3.267

8.  Apyrogenic synthetic desmuramyldipeptide, LK-409, with immunomodulatory properties.

Authors:  M Sollner; V Kotnik; S Pecar; A Stace; S Simcic; L Povsic; B Herzog-Wraber; L Klampfer; A Ihan; P Grosman
Journal:  Agents Actions       Date:  1993-03

9.  A dried preparation of liposomes containing muramyl tripeptide phosphatidylethanolamine as a potent activator of human blood monocytes to the antitumor state.

Authors:  S Sone; T Utsugi; P Tandon; M Ogawara
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

10.  Prophylaxis and treatment of experimental lung metastases in mice after treatment with liposome-encapsulated 6-O-stearoyl-N-acetylmuramyl-L-alpha-aminobutyryl-D-isoglutamine.

Authors:  G Lopez-Berestein; L Milas; N Hunter; K Mehta; E M Hersh; C G Kurahara; M Vandupas; D A Eppstein
Journal:  Clin Exp Metastasis       Date:  1984 Apr-Jun       Impact factor: 5.150
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.